Net income
1.27 million USD
2022-04-01 – 2023-03-31
Fundies. English
Viveon Health Acquisition Corp.
EDGAR21 filing records in this dataset, filed from 2020-12-04 to 2024-06-06. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 77.9 thousand USD Source
Exact value
77861 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 5.03 million shares Source
Exact value
5031250 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-1.49 million USD
2022-04-01 – 2023-03-31
Exact inputs and evidence
- Operating cash flow: -1023969 USD · 2022-01-01 – 2022-06-30 Source
- Operating cash flow: -433624 USD · 2022-01-01 – 2022-03-31 Source
- Operating cash flow: -1480143 USD · 2022-01-01 – 2022-09-30 Source
- Operating cash flow: -1023969 USD · 2022-01-01 – 2022-06-30 Source
- Operating cash flow: -1753388 USD · 2022-01-01 – 2022-12-31 Source
- Operating cash flow: -1480143 USD · 2022-01-01 – 2022-09-30 Source
- Operating cash flow: -173986 USD · 2023-01-01 – 2023-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-06-06.
Financial data available through: 2022-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 2 of 11 periods available· newest 2022-12-31
- Net income: 2 of 11 periods available· newest 2022-12-31
- Operating cash flow: 2 of 11 periods available· newest 2022-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2022-12-31
- Total liabilities: 2 of 11 periods available· newest 2022-12-31
- Current assets: 2 of 11 periods available· newest 2022-12-31
- Current liabilities: 2 of 11 periods available· newest 2022-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2022-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2022-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
-124.3%Prior period
USD 2.49 million
–
Current period
−USD 605,294
–
Exact inputs and evidence
-605294 − 2489829 = -3095123 USD
2489829 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-605294 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 328,946Prior period
−USD 2.08 million
–
Current period
−USD 1.75 million
–
Exact inputs and evidence
-1753388 − -2082334 = 328946 USD
-2082334 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-1753388 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | USD 2.49 million Exact valueExact value: 2489829 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.08 million Exact valueExact value: -2082334 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 605,294 Exact valueExact value: -605294 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.75 million Exact valueExact value: -1753388 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
21 filings · 445 latest values · 445 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001823857, 1823857, VHAQ, edgar:1823857
Also known as VIVEON HEALTH ACQUISITION CORP., VIVEON HEALTH ACQUISITION CORP., Viveon Health Acquisition Corp.